首页 | 本学科首页   官方微博 | 高级检索  
     

痰热清注射液联合阿奇霉素治疗小儿支原体肺炎疗效分析
引用本文:王霖,吴澄清. 痰热清注射液联合阿奇霉素治疗小儿支原体肺炎疗效分析[J]. 儿科药学, 2013, 0(10): 28-30
作者姓名:王霖  吴澄清
作者单位:昆明医科大学附属儿童医院,云南昆明650034
摘    要:目的:探讨痰热清注射液联合阿奇霉素治疗小儿支原体肺炎的临床疗效。方法:将我院2007--2009年收治的120例支原体肺炎患儿按随机数表法分为观察组和对照组各60例,均给予止咳化痰、退热等常规综合治疗。在此基础上对照组给予阿奇霉素序贯治疗:阿奇霉素10mg/(k·d)静脉滴注,1次/天,连用3~5d,病情好转后改口服,用3d停4d,疗程10~1,4d;观察组在对照组治疗基础上,给予痰热清注射液0.3—0.5mL/(kg·d),1次/天,每日最大剂量20mL,静脉滴注治疗7d。治疗期间停用其他抗茵药物。结果:(1)治疗后观察组血清IL-6、TNF—OL、CRP下降水平均较对照组更明显(P〈0.01);(2)观察组和对照组发热、咳嗽、肺部哆音、X线胸片阴影消失时间分别为(5.6±2.3)d vs (7.4±3.8)d、(7.1±3.5)dm(9.3±4.1)d、(7.9±3.9)d vs (10.5±4.7)d、(12.3±4.6)d vs (15.1±5.4)d,组问比较差异均有统计学意义(P〈0.05);(3)观察组和对照组总有效率分别为98.3%vs86.7%(P〈0.05),不良反应发生率分别为15.0%、18.3%(P〉0.05)。结论:痰热清注射液联合阿奇霉素治疗小儿支原体肺炎较单用阿奇霉素疗效更显著,且不会增加不良反应。

关 键 词:支原体  肺炎  痰热清注射液  阿奇霉素  儿童

The Effect of Tanreqing Injection and Azithromycin in the Treatment of Children with Mycoplasma Pneumonia Pneumoniae
Wang Lin,Wu Chengqing. The Effect of Tanreqing Injection and Azithromycin in the Treatment of Children with Mycoplasma Pneumonia Pneumoniae[J]. Journal of Pediatric Pharmacy, 2013, 0(10): 28-30
Authors:Wang Lin  Wu Chengqing
Affiliation:( Children' s Hospital of Kunming Medical University, Yunnan Kunming 650034, China )
Abstract:Objective: To investigate the clinical curative effect of azithromycin combined with Tanreqing injection in treating children with mycoplasma pneumoniae pneumonia (MPP). Methods: One hundred and twenty cases of children with MPP were randomly divided into an experimental group (60 cases ) and a control group (60 cases ) in our hospital from 2007 to 2009, all of then were given comprehensive therapy such as relieving cough, sputum and fever. The control group was treated with azithromycin 10 rag/( kg · d) , once a day, lasts 3 N 5 days; the experimental group was treated with azithromycin combined with Tanreqing injection 0.3 - 0.5 mL/( kg · d) , qd. Results: The time to defervesce, disappearance time of cough and pulmonary tales, and the time to clear lung fields on chest X-ray report in the experimental group and the control group were ( 5.6 ± 2.3 ) days vs ( 7.4 ± 3. 8 ) days, (7.1±3.5) daysvs (9.3±4.1) days, (7.9±3.9) daysvs (10.5±4.7) days, and (12.3±4.6) daysvs (15.1±5.4) days. The differences were statistically significant (P〈0.05). The total effective rate of the experimental group (98.3%) was significantly higher than that of the control group (86.7%) ; there were significant differences between the two groups (P〈0.05). Conclusions: The effect of azithromycin combined with Tanreqing injection in treating children with mycoplasma pneumoniae pneumonia is better than that of only azithromycin. It is worth promoting.
Keywords:Mycoplasma Pneumoniae  Pneumonia  Tanreqing injection  Azithromycin  Children
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号